1. Home
  2. AGIO vs BLBD Comparison

AGIO vs BLBD Comparison

Compare AGIO & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

N/A

Current Price

$32.48

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

N/A

Current Price

$55.60

Market Cap

1.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
AGIO
BLBD
Founded
2007
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
AGIO
BLBD
Price
$32.48
$55.60
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$46.25
★ $89.13
AVG Volume (30 Days)
★ 686.1K
440.7K
Earning Date
10-29-2026
08-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 22.78
EPS
N/A
★ 7.33
Revenue
$43,011,000.00
★ $1,480,099,000.00
Revenue This Year
$237.78
$18.37
Revenue Next Year
$92.30
$15.68
P/E Ratio
★ N/A
$7.65
Revenue Growth
N/A
★ 9.87
52 Week Low
$22.24
$46.14
52 Week High
$46.00
$83.39

Technical Indicators

Market Signals
Indicator
AGIO
BLBD
Relative Strength Index (RSI) 48.96 31.89
Support Level $32.17 $52.89
Resistance Level $35.77 $64.56
Average True Range (ATR) 1.18 2.01
MACD -0.00 -0.27
Stochastic Oscillator 51.25 0.00

Price Performance

Historical Comparison
AGIO
BLBD

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: